相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。8-Hydroxyquinoline, Derivatives and Metal-Complexes: A Review of Antileukemia Activities
Carolina Bissani Gasparin et al.
CHEMISTRYSELECT (2023)
Heteroleptic copper(II) complexes of prenylated flavonoid osajin behave as selective and effective antiproliferative and anti-inflammatory agents
Jan Vanco et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2022)
A concise review on cobalt Schiff base complexes as anticancer agents
Kanisha Kar et al.
POLYHEDRON (2022)
Connecting copper and cancer: from transition metal signalling to metalloplasia
Eva J. Ge et al.
NATURE REVIEWS CANCER (2022)
Target based chemotherapeutic advancement of ruthenium complexes
Pragti et al.
COORDINATION CHEMISTRY REVIEWS (2021)
Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable In Vitro Cytotoxicity and Anti-inflammatory Effects
Jan Vanco et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Synthesis and biological evaluation of triterpenoid thiazoles derived from betulonic acid, dihydrobetulonic acid, and ursonic acid
Lucie Borkova et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
Jiabei Zhou et al.
FRONTIERS IN PHARMACOLOGY (2020)
New copper complexes inducing bimodal death through apoptosis and autophagy in A549 cancer cells
Noor Shad Gul et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2020)
Review of comparative studies of cytotoxic activities of Pt(II), Pd(II), Ru(II)/(III) and Au(III) complexes, their kinetics of ligand substitution reactions and DNA/BSA interactions
Reinner O. Omondi et al.
INORGANICA CHIMICA ACTA (2020)
Metallacarborane Sulfamides: Unconventional, Specific, and Highly Selective Inhibitors of Carbonic Anhydrase IX
Bohumir Gruner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Pharmacogenomics of CYP2C9: Functional and Clinical Considerations
Ann K. Daly et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives
Tatjana Lazarevic et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Vanadium, Ruthenium and Copper Compounds: A New Class of Nonplatinum Metallodrugs with Anticancer Activity
Ignacio Esteban Leon et al.
CURRENT MEDICINAL CHEMISTRY (2017)
Effect of [Cu(4,7-dimethyl-1,10-phenanthroline)(acetylacetonato)]NO3, Casiopeina III-Ea, on the activity of cytochrome P450
Cristina Campero-Peredo et al.
TOXICOLOGY IN VITRO (2016)
Ferrocifen type anti cancer drugs
Gerard Jaouen et al.
CHEMICAL SOCIETY REVIEWS (2015)
Advances in cobalt complexes as anticancer agents
Catherine R. Munteanu et al.
DALTON TRANSACTIONS (2015)
Auranofin: Repurposing an Old Drug for a Golden New Age
Christine Roder et al.
DRUGS IN R&D (2015)
Advances in Copper Complexes as Anticancer Agents
Carlo Santini et al.
CHEMICAL REVIEWS (2014)
On the binding affinity of macromolecular interactions: daring to ask why proteins interact
Panagiotis L. Kastritis et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2013)
Casiopeina II-gly and bromo-pyruvate inhibition of tumor hexokinase, glycolysis, and oxidative phosphorylation
Alvaro Marin-Hernandez et al.
ARCHIVES OF TOXICOLOGY (2012)
Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation
Cristina Trejo-Solis et al.
BMC CANCER (2012)
Cellular responses induced by Cu(II) quinolinonato complexes in human tumor and hepatic cells
Zdenek Travnicek et al.
CHEMISTRY CENTRAL JOURNAL (2012)
In vitro cytotoxicity, DNA cleavage and SOD-mimic activity of copper(II) mixed-ligand quinolinonato complexes
Roman Buchtik et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Flexibility of human cytochrome P450 enzymes: Molecular dynamics and spectroscopy reveal important function-related variations
Tereza Hendrychova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Synthesis, characterization, DNA interaction and cleavage, and in vitro cytotoxicity of copper(II) mixed-ligand complexes with 2-phenyl-3-hydroxy-4(1H)-quinolinone
Roman Buchtik et al.
DALTON TRANSACTIONS (2011)
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Michael Frezza et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Towards Prediction of In Vivo Intestinal Absorption Using a 96-Well Caco-2 Assay
Suzanne Skolnik et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
Anshul Gupte et al.
CANCER TREATMENT REVIEWS (2009)
Synthesis, characterization, DNA-binding study and anticancer properties of ternary metal(II) complexes of edda and an intercalating ligand
Chew Hee Ng et al.
DALTON TRANSACTIONS (2008)
Copper and human health: Biochemistry, genetics, and strategies for modeling dose-response relationships
Bonnie Ransom Stern et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2007)
A literature review of enzyme kinetic parameters for CYP3A4-mediated metabolic reactions of 113 drugs in human liver microsomes: Structure-kinetics relationship assessment
HZ Bu
CURRENT DRUG METABOLISM (2006)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Profiling drug-like properties in discovery research
L Di et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2003)
Cytochromes P450 and metabolism of xenobiotics
P Anzenbacher et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Induction of apoptosis by a novel copper-based anticancer compound, casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells
A De Vizcaya-Ruiz et al.
TOXICOLOGY IN VITRO (2000)
分享论文
